Evidence map›Paper›PMID 41194482›Full record

ArticleBrain and behavior2025

Test-Retest Reliability of Single Spectral Power and Spectral Power Ratios in Relative and Absolute Values.

Jinwon Chang

Abstract read
In one paragraph

Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jinwon ChangDepartment of Psychology, Williams College, Williamstown, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe current study provides the first systematic evaluation of the test-retest reliability of electroencephalography (EEG) spectral power ratios alongside absolute and relative spectral power using two independent datasets. This approach aims to identify reproducible and clinically meaningful EEG features for longitudinal and diagnostic applications.

methodTwo separate datasets of healthy adults were analyzed. Dataset 1 included 60 participants with EEGs recorded across three sessions (two on the same day and one month later), while Dataset 2 involved 74 participants recorded 1 h apart. Absolute, relative, and ratio-based spectral features were computed across five brain regions using fast Fourier transform (FTP). Intraclass correlation coefficients (ICCs) were calculated to assess short- and long-term test-retest reliability. FINDING: Spectral power ratios, particularly the alpha/beta ratio, consistently outperformed single-band absolute and relative power features in reliability. Absolute alpha/beta ratios in the central, parietal, occipital, and temporal regions showed ICC values exceeding 0.75 across both datasets. These results were stable across different intervals and independent recording systems, demonstrating strong generalizability.

conclusionThis study demonstrates that spectral power ratios, especially the absolute alpha/beta ratio, are highly reliable EEG features. By leveraging two independent datasets, we establish their reproducibility across different populations and conditions. Our findings position spectral power ratios as robust, reproducible biomarkers for clinical EEG applications. This is the first study to rigorously validate their reliability across independent datasets, laying a foundation for their use in diagnostic and longitudinal monitoring tools.

Indexed as

BrainElectroencephalographyAdultAlpha RhythmFemaleFourier AnalysisHumansMaleMiddle AgedReproducibility of ResultsYoung Adultelectroencephalographyresting statespectral powertest–retest reliability

Identifiers

PMID41194482
PMCPMC12589806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.